Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma

International Journal of Epidemiology

Volumn 34, Issue 6, 2005, Pages 1310-1318

  Chen, Chun Chieh ^a   Yang, Shi Yi ^b   Liu, Chun Jen ^c   Lin, Chih Lin ^d   Liaw, Yun Fan ^e   Lin, Shi Ming ^e   Lee, Shou Dong ^f   Chen, Pei Jer ^c   Chen, Chien Jen ^b   Yu, Ming Whei ^b  

^a CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d JEN AI HOSPITAL   (Taiwan)

^e CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^f NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Cytokine; DNA repair; Hepatitis B; Hepatocellular carcinoma

Indexed keywords

ANTIOXIDANT; CYTOKINE; GLUTATHIONE TRANSFERASE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

HEALTH AND DISEASE;

ADULT; ALLELE; ARTICLE; CANCER RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE CARRIER; DNA REPAIR; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B; HIGH RISK POPULATION; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING;

HEPATITIS B VIRUS;

EID: 84984545985     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyi191     Document Type: Article

References (40)

1. Lee WM. Hepatitis B virus infection. N Engl J Med 1997;337:1733-45.
2. Yu MW, Chen CJ. Hepatitis B and C viruses in the development of hepatocellular carcinoma. Crit Rev Oncol Hematol 1994;17:71-91.
3. Chen PJ, Chen DS. Hepatitis B virus infection and hepatocellular carcinoma: Molecular genetics and clinical perspectives. Semin Liver Dis 1999;19:253-62.
4. Furuta T, El-Omar EM, Xiao F, Shirai N, Takashima M, Sugimurra H. Interleukin 1β polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology 2002;123:92-105.
5. Hwang IR, Kodama T, Kikuchi S et al. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1β production in Helicobacter pylori infection. Gastroenterology 2002;123:1793-803.
6. Figueiredo C, Machado JC, Pharoah P et al. Helicobacter pylori and interleukin 1 genotyping: An opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 2002;94:1680-87.
7. Machado JC, Figueiredo C, Canedo P et al. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 2003;125:364-71.
8. Vassali P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol 1992;10:411-52.
9. Tilg H, Diehl AM. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med 2000;343:1467-76.
10. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-67.
11. Jaiswal M, LaRusso NF, Burgart LJ, Gores GJ. Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res 2000;60: 184-90.
12. Cooke MS, Evans MD, DizdarogluM, Lunec J. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 2003;17:1195-214.
13. Shimoda R, Nagashima M, Sakamoto M et al. Increased formation of oxidative DNA damage, 8-hydroxydeoxyguanosine, in human livers with chronic hepatitis. Cancer Res 1994;54:3171-72.
14. Hagen TM, Huang S, Curnutte J et al. Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma. Proc Natl Acad Sci USA 1994;91:12808-12.
15. Seidegard J, Vorachek WR, Pero RW, Pearson WR. Hereditary differences in the expression of human glutathione S-transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci USA 1988;85:7293-97.
16. Pemble S, Schroeder KR, Spencer SR et al. Human glutathione S-transferase theta (GSTT1): CDNA cloning and the characterization of a genetic polymorphism. Biochem J 1994;300:271-76.
17. Yu MW, Yang SY, Pan IJ et al. Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinoma. J Natl Cancer Inst 2003;95:1485-88.
18. Lindahl T, Wood RD. Quality control by DNA repair. Science 1999;286:1897-905.
19. Whitehouse CJ, Taylor RM, Thistlewaite A et al. XRCC1 stimulates human polynucleotide kinase activity at damaged DNA termini and accelerates DNA single-strand break repair. Cell 2001;104:107-17.
20. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996;87:2095-147.
21. Mitchell RJ, Farrington SM, Dunlop MG, Campbell H. Mismatch repair genes hMLH1 and hMSH2 and colorectal cancer: HuGE review. Am J Epidemiol 2002;156:885-902.
22. El-Omar EM, Carrington M, Chow WH et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000;404:398-402.
23. Santtila S, Savinainen K, Hurme M. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1β production in vitro. Scand J Immunol 1998;47:195-98.
24. Stokkers PCF, van Aken BE, Basoski N, Reitsma PH, Tytgat GNJ, van Deventer SJH. Five genetic markers in the interleukin family in relation to inflammatory bowel disease. Gut 1998;43:33-39.
25. Wang Y, Kato N, Hoshida Y et al. Interleukin-1β gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection. Hepatology 2003;37:65-71.
26. 1-DNA adducts and glycophorin A variant frequency. Cancer Res 1999;59:2557-61.
27. Kim SU, Park SK, Yoo KY et al. XRCC1 genetic polymorphism and breast cancer risk. Pharmacogenetics 2002;12:335-38.
28. Park JY, Lee SY, Jeon HS et al. Polymorphism of the DNA repair gene XRCC1 and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev 2002;11:23-27.
29. Ito E, Yanagisawa Y, Iwahashi Y et al. A core promoter and a frequent single-nucleotide polymorphism of the mismatch repair gene hMLH1. Biochem Biophys Res Comm 1999;256:488-94.
30. 2P-DNA adducts in a sample of healthy subjects. Carcinogenesis 2001;22:1437-45.
31. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor a promoter on transcriptional activation. Proc Natl Acad Sci USA 1997;94:3195-99.
32. Liu K, Muse S. PowerMarker: New genetic data analysis software. Version 3.0. Free program distributed by the author over the Internet from http://www.powermarker.net. 2004.
33. Jackson AL, Chen R, Loeb LA. Induction ofmicrosatellite instability by oxidative DNA damage. Proc Natl Acad Sci USA 1998;95:12468-73.
34. Gasche C, Chang CL, Rhees J, Goel A, Boland CR. Oxidative stress increases frameshift mutations in human colorectal cancer cells. Cancer Res 2001;61:7444-48.
35. Fleisher AS, Esteller M, Harpaz N et al. Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1. Cancer Res 2000;60:4864-68.
36. Jaloszynski P, Jaruga P, Olinski R et al. Oxidative DNA base modifications and polycyclic aromatic hydrocarbons DNA adducts in squamous cell carcinoma of the larynx. Free Radic Res 2003;37:231-40.
37. McAllister-Sistilli CG, Ciggiula AR, Knopf S, Rose CA, Miller AL, Donny EC. The effects of nicotine on the immune system. Psychoneuroendocrinology 1998;23:175-87.
38. Yu MW, Hsu FC, Sheen IS et al. Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. Am J Epidemiol 1997;145:1039-47.
39. Wang CS,Wang ST, Chang TT, Yao WJ, Chou P. Smoking and alanine aminotransferase levels in hepatitis C virus infection: Implications for prevention of hepatitis C virus progression. Arch Intern Med 2002;162:811-15.
40. Yu MW, Yeh SH, Chen PJ et al. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: A prospective study in men. J Natl Cancer Inst 2005;97:265-72.